Trials / Terminated
TerminatedNCT01834625
Prognostic Value of Aβ Imaging in NPH Prior to Shunt Placement
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 2 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
In this pilot study the investigators shall prospectively in a blinded fashion evaluate with Aβ PET in patients committed to shunt surgery and then investigate the relationship of these biomarkers with outcome on gait, cognition and urinary control improvement in the short term (3 months) and long term (1 year). The imaging agent will be provided by AVID. Furthermore the study will standardize imaging studies using florbetapir F 18 PET to provide information on amyloid burden.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | PET scan |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2017-03-01
- Completion
- 2017-10-01
- First posted
- 2013-04-18
- Last updated
- 2022-02-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01834625. Inclusion in this directory is not an endorsement.